West Pharmaceutical Services (WST) is up 7.3% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears tied to a strong third-quarter earnings release that showed faster profit growth, better-than-expected sales, and a higher full-year outlook. Investors also seem to be responding to strength in the company’s high-value components business, which helped drive margin expansion and reinforced confidence in demand trends.
Details:
Sources:
West Pharmaceutical Services, SEC, Investing.com
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$WST Insider Trading Activity
$WST insiders have traded $WST stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $WST stock by insiders over the last 6 months:
- ANNETTE F FAVORITE (Sr. VP & Chief HR Officer) has made 0 purchases and 6 sales selling 15,659 shares for an estimated $5,443,749.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$WST Hedge Fund Activity
We have seen 418 institutional investors add shares of $WST stock to their portfolio, and 356 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 2,325,068 shares (+186.0%) to their portfolio in Q2 2026, for an estimated $834,699,412
- JPMORGAN CHASE & CO added 1,164,527 shares (+inf%) to their portfolio in Q2 2026, for an estimated $418,065,193
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,012,343 shares (+127.7%) to their portfolio in Q2 2026, for an estimated $363,431,137
- APG ASSET MANAGEMENT N.V. removed 706,700 shares (-55.8%) from their portfolio in Q2 2026, for an estimated $253,705,300
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 583,984 shares (+inf%) to their portfolio in Q2 2026, for an estimated $209,650,256
- BANK OF NEW YORK MELLON CORP removed 422,035 shares (-17.1%) from their portfolio in Q2 2026, for an estimated $151,510,565
- VIKING GLOBAL INVESTORS LP removed 416,948 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $149,684,332
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$WST Analyst Ratings
Wall Street analysts have issued reports on $WST in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wolfe Research issued a "Outperform" rating on 06/02/2026
To track analyst ratings and price targets for $WST, check out Quiver Quantitative's $WST forecast page.
$WST Price Targets
Multiple analysts have issued price targets for $WST recently. We have seen 5 analysts offer price targets for $WST in the last 6 months, with a median target of $390.0.
Here are some recent targets:
- Kallum Titchmarsh from Morgan Stanley set a target price of $365.0 on 07/09/2026
- Daniel Markowitz from Evercore ISI Group set a target price of $410.0 on 07/06/2026
- Paul Knight from Keybanc set a target price of $390.0 on 07/02/2026
- Luke Sergott from Barclays set a target price of $400.0 on 06/09/2026
- Steven Etoch from Stephens & Co. set a target price of $360.0 on 06/02/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
